Disease Atlas / Disease detail
We have summarized the concept, evaluation, and management principles of susceptibility to diabetic microvascular complications in an easy-to-understand manner.
microvascular complications of diabetes, susceptibility
Start with the essentials, then explore the patient and research views.
Public revision · 8bcea2965f20
A structured guide for understanding the disease and preparing for clinical conversations.
Susceptibility to diabetic microvascular complications refers to the predisposition in people with diabetes to developing complications related to microvessels, such as the retina, kidneys, and peripheral nerves.
Representative clinical manifestations include diabetic retinopathy, kidney damage that may be accompanied by albuminuria, and diabetic peripheral neuropathy.
Related factors include the duration of diabetes and the status of blood glucose control, and blood pressure, dyslipidemia, smoking, renal function, and individual biological differences can also exert an influence.
Persistent hyperglycemia can cause metabolic and inflammatory changes in vascular and nerve tissues, potentially damaging microvascular function and organ structure.
The risk of complications varies individually depending on the control status of blood glucose, blood pressure, and lipids, the type and duration of diabetes, age, comorbidities, and lifestyle factors.
In the early stages, there may be no symptoms, but as it progresses, problems such as decreased vision, edema, decreased sensation or pain, and delayed wound healing may appear depending on the affected organs.
Diagnostic evaluation is conducted based on medical history and physical examination, involving eye exams, urine albumin and kidney function assessment, and foot and peripheral nerve examinations, tailored to the level of risk.
Since the cause or rate of progression of complications cannot be determined by a single test result alone, transient changes and the influence of other diseases must be considered together.
The broad framework of management involves comprehensively controlling blood glucose, blood pressure, and lipid risks, while continuing smoking cessation, foot care, and regular screening for affected organs.
Rather than always reversing damage that has already occurred, treatment focuses on reducing risk factors and slowing the progression of complications and additional damage.
Since changes in test results may appear before symptoms, regular follow-up is important, and participation in research alone does not guarantee treatment efficacy or standard care.
In clinical practice, it is important to check the type and duration of diabetes, recent test trends, changes in vision, urine, and sensation, medications and side effects, and the schedule for tests and follow-up observations.
This material is for educational purposes and general information only, and cannot replace individual diagnosis or treatment. Please consult with medical professionals regarding judgments on symptoms or test results.
A trial registry status does not establish efficacy or regulatory approval.
MONDO · ONTOLOGY